ONC · BeOne Medicines Ltd. · Documents
$384.50
+14.33 (+3.87%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$42.11B
Shares
113.77M
Volume · Oct 20
408.37K
Avg daily vol (3M)
386.32K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| Investor Event Transcript | — | 2026-09-14 | 2026-09-30 | |
| 8-K | — | 2026-08-26 | — | |
| 10-Q | — | 2026-08-05 | 2026-06-30 | |
| 8-K | — | 2026-08-05 | — | |
| 8-K | — | 2026-06-26 | — | |
| 8-K | — | 2026-06-11 | — | |
| Investor Event Transcript | — | 2026-06-08 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-06-08 | 2026-06-30 | |
| 8-K | — | 2026-05-15 | 2026-05-13 | |
| 8-K | — | 2026-05-06 | — | |
| S-3ASR | — | 2026-05-06 | — | |
| S-3ASR | — | 2026-05-06 | — | |
| 10-Q | — | 2026-05-06 | 2026-03-31 | |
| ARS | — | 2026-04-28 | 2025-12-31 | |
| DEFA14A | — | 2026-04-28 | — | |
| DEF 14A | — | 2026-04-28 | 2026-06-11 | |
| PRE 14A | — | 2026-04-16 | 2026-06-11 | |
| 8-K | — | 2026-04-14 | — | |
| 10-K | — | 2026-02-26 | 2025-12-31 | |
| 8-K | — | 2026-02-26 | — | |
| 8-K | — | 2025-12-19 | 2025-12-16 | |
| 8-K | — | 2025-12-18 | 2025-12-17 | |
| 8-K | — | 2025-11-19 | 2025-11-13 | |
| 10-Q | — | 2025-11-06 | 2025-09-30 | |
| 8-K | — | 2025-11-06 | — | |
| 8-K | — | 2025-08-29 | — | |
| 8-K | — | 2025-08-25 | — | |
| 10-Q | — | 2025-08-06 | 2025-06-30 | |
| 8-K | — | 2025-08-06 | — | |
| 8-K | — | 2025-05-21 | — | |
| 8-K | — | 2025-05-13 | — | |
| 10-Q | — | 2025-05-07 | 2025-03-31 | |
| 8-K | — | 2025-05-07 | — | |
| 8-K | — | 2025-04-29 | — | |
| 8-K | — | 2025-04-28 | — | |
| 8-K | — | 2025-04-28 | — | |
| DEFA14A | — | 2025-04-07 | — | |
| ARS | — | 2025-04-07 | 2024-12-31 | |
| DEF 14A | — | 2025-04-07 | 2025-05-21 | |
| PRE 14A | — | 2025-03-27 | 2025-05-21 | |
| DEFA14A | — | 2025-03-10 | — | |
| 10-K/A | — | 2025-02-28 | 2024-12-31 | |
| S-4/A | — | 2025-02-28 | — | |
| 8-K | — | 2025-02-27 | — | |
| 10-K | — | 2025-02-27 | 2024-12-31 | |
| S-4/A | — | 2025-01-21 | — | |
| 8-K | — | 2025-01-13 | — | |
| 10-K/A | — | 2025-01-08 | 2023-12-31 | |
| 8-K | — | 2024-12-23 | — | |
| 8-K | — | 2024-12-10 | 2024-12-09 |
Showing 1–50 of 244 filings
Key facts
CIK
1651308
CUSIP
07725L102
13F (30d)
33 filings
31 filers
Visit website
Investor relations